NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS FOR USE IN DOWN SYNDROME AND ALZHEIMER`S… Application WO-2023105283-A1 World Intellectual Property Organisation (WIPO) 15 Jun 2023